Beam Therapeutics BEAM
NASDAQ BEAM
$24.50 +0.11 (+0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Price to FCF (2022)

Updated

Beam Therapeutics' (BEAM) Price to FCF came in at 85.00 for Q3 2022, up 284.1% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Price to FCF (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Beam Therapeutics 2.52 Bn 2.52 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 85.00
Jun 30, 2022 22.13
Mar 31, 2022 26.97
API Access

Beam Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=BEAM&period=max&api_key=YOUR_API_KEY